Anteris Posts $78.5M Nine-Month Loss; Material Weaknesses Still Unremediated
AVR sits 78% above its 52-week low of $3.3.
Summary
Anteris reported a $78.5M nine-month net loss and $236.3M in cash, while disclosing that its material weaknesses in internal control remained unremediated as of September 30, 2026.
Key Events · Earnings and Guidance · AVR
-
Q3 Loss Widens on PARADIGM Spending
Net loss was $26.8M for Q3 2026 versus $22.2M a year earlier; nine-month net loss reached $78.5M. R&D rose 27% to $21.3M in the quarter, driven by PARADIGM Trial enrollment and manufacturing scale-up.
-
Cash Cushion From January Raises
Cash, cash equivalents and restricted cash totaled $236.3M at September 30, 2026, versus $12.6M at December 31, 2025, after the $320.0M gross January offerings. Management says this funds at least the next 12 months.
-
Material Weaknesses Remain Unremediated
Previously reported material weaknesses in internal control over financial reporting remained unremediated as of September 30, 2026, and management concluded disclosure controls and procedures were not effective.
-
Large Accelerated Filer Status Ahead
Anteris expects to cease qualifying as an emerging growth company and smaller reporting company with the FY2026 10-K, triggering auditor ICFR attestation and full non-scaled disclosure beginning with the March 31, 2027 10-Q.
Analysis · AVR · Industrial Applications And Services
Anteris burned $72.4M of operating cash in nine months and lost $78.5M, but the January 2026 raises left it with $236.3M in cash — enough, management says, for at least the next 12 months. The bigger issue is controls: the material weaknesses first flagged for 2023-2024 remain unremediated as of September 30, 2026, and management concluded disclosure controls were not effective. That matters more than usual because the company expects to lose emerging-growth and smaller-reporting-company status with the FY2026 10-K, which brings auditor attestation on internal control and full non-scaled disclosure starting with the March 2027 10-Q. The $250M ATM remains untouched, so dilution risk is latent rather than realized.
How filings like this one have moved
In the 30 days to Nov 11, 2026, 48.1% of the 1752 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.29%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AVR was trading at $5.89 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $574.2M. The 52-week trading range was $3.30 to $11.06. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.